Skip to main content
. 2020 Mar 10;18(Suppl 1):e12953. doi: 10.1111/mcn.12953

Table 1.

Selected sociodemographic and health characteristics of nonpregnant women 15– 49 years, by anaemia status Nepal National Micronutrient Status Survey, Nepal, 2016 (n = 1, 918)

Anaemia a (n = 355, 20.2%; 95% CI [17.6, 22.8]) No anaemia a (n = 1, 563, 79.8%; 95% CI [77.1, 82.4]) Total (n = 1, 918)
n n P b n
Sociodemographic characteristics
Age group, % 0.4
15– 29 years 169 47.8 (41.8, 53.7) 801 50.9 (47.6, 54.1) 970 50.2 (47.6, 52.8)
30‐49 years 186 52.2 (46.3, 58.2) 762 49.1 (45.9, 52.4) 948 49.8 (47.2, 52.4)
Lactating, % 94 23.2 (17.5, 29.0) 440 26.0 (22.8, 29.1) 0.4 534 25.4 (22.6, 28.2)
Gave birth in last 5 years, % 138 37.9 (31.4, 44.4) 602 36.5 (32.9, 40.0) 0.7 740 36.7 (33.7, 39.8)
Married/ cohabitating, % 296 83.2 (78.3, 88.2) 1,332 85.5 (83.1, 88.0) 0.4 1,628 85.1 (82.9, 87.2)
Rurality, % 0.5
Rural 314 88.0 (80.8, 95.2) 1,338 86.1 (80.0, 92.2) 1,652 86.5 (80.5, 92.5)
Urban 41 12.0 (4.8, 19.2) 225 13.9 (7.8, 20.0) 266 13.5 (7.5, 19.5)
Ecological zone, % <0.0001
Mountain 33 3.5 (2.1, 4.9) 288 7.1 (6.3, 7.9) 321 6.4 (5.6, 7.1)
Hill 109 26.8 (20.8, 32.7) 711 48.7 (45.5, 51.9) 820 44.3 (41.5, 47.1)
Terai 213 69.7 (63.6, 75.8) 564 44.2 (41.1, 47.3) 777 49.3 (46.6, 52.0)
Household wealth quintile 0.06
Poorest 96 20.1 (14.6, 25.6) 495 22.9 (18.8, 27.1) 591 22.4 (18.4, 26.3)
Middle 142 41.2 (34.4, 48.0) 516 33.1 (28.2, 38.0) 658 34.8 (30.3, 39.2)
Wealthiest 117 38.6 (31.0, 46.3) 552 44.0 (37.0, 50.9) 669 42.9 (36.4, 49.4)
Ethnicity, % 0.03
Brahmin or Chettri 120 32.7 (25.1, 40.2) 655 38.8 (33.3, 44.3) 775 37.5 (32.2, 42.9)
Dalit 54 14.2 (8.5, 19.9) 255 15.3 (11.6, 19.0) 309 15.1 (11.4, 18.8)
Janajati 131 35.3 (26.4, 44.2) 498 30.8 (25.3, 36.3) 629 31.7 (26.4, 37.0)
Other Terai ethnicities c 37 13.4 (6.2, 20.7) 69 7.9 (4.1, 11.7) 106 9.0 (5.0, 13.0)
Newar 4 2.1 (0.1, 4.1) d 60 5.5 (2.9, 8.0) 64 4.8 (2.7, 6.9)
Muslim 9 2.3 (0.2, 4.5) d 26 1.8 (0.5, 3.1) 35 1.9 (0.6, 3.2)
Schooling (grades completed), % 0.5
No grades 134 34.5 (28.0, 41.1) 518 31.1 (27.1, 35.2) 652 31.8 (28.0, 35.6)
1– 8 grades 107 33.1 (26.6, 39.7) 505 32.3 (29.3, 35.4) 612 32.5 (29.7, 35.3)
≥9 grades 114 32.3 (25.5, 39.1) 540 36.6 (32.4, 40.7) 654 35.7 (32.0, 39.4)
Improved water source e , % 344 96.7 (94.3, 99.1) 1,497 95.2 (91.9, 98.5) 0.2 1,841 95.5 (92.5, 98.5)
Open defecation, % 55 20.3 (12.3, 28.3) 111 10.0 (5.8, 14.1) <0.0001 166 12.0 (7.6, 16.5)
Earth floor, % 253 65.9 (58.4, 73.4) 1,014 57.9 (51.3, 64.4) 0.03 1,267 59.5 (53.3, 65.6)
Severe household food insecurity, % 31 7.1 (3.8, 10.3) 96 5.3 (3.6, 6.9) 0.3 127 5.6 (4.1, 7.1)
Health characteristics
Hemoglobin f , g/ dL 355 10.9 (10.8, 11.0) 1563 13.3 (13.2, 13.4) <0.0001 1918 12.8 (12.7, 12.9)
Anaemia severity g
No anaemia 0 1,563 <0.0001 1,563 79.8 (77.1, 82.4)
Mild 224 62.7 (57.0, 68.5) 0 224 12.7 (10.6, 14.7)
Moderate 125 35.3 (29.1, 41.4) 0 125 7.1 (5.6, 8.7)
Severe 6 2.0 (0.0, 4.0) d 0 6 0.4 (0.0, 0.8) d
Anthropometry h , % 0.01
Underweight 74 18.8 (13.4, 24.1) 223 14.1 (11.8, 16.4) 297 15.0 (12.9, 17.2)
Normal weight 233 64.7 (59.3, 70.2) 976 60.3 (56.8, 63.8) 1,209 61.2 (58.1, 64.2)
Overweight/ obesity 48 16.5 (11.0, 22.0) 364 25.6 (22.3, 28.9) 412 23.8 (20.6, 27.0)
2‐week morbidity recall, %
Fever 43 10.8 (7.0, 14.6) 257 14.7 (12.2, 17.2) 0.09 300 13.9 (11.7, 16.1)
Cough 42 10.9 (7.3, 14.6) 276 16.2 (13.7, 18.6) 0.02 318 15.1 (12.9, 17.3)
Diarrhoea 29 9.4 (5.2, 13.6) 155 9.7 (7.7, 11.6) 0.9 184 9.6 (7.8, 11.4)
CRP, mg/ L 355 0.44 (0.36, 0.53) 1,563 0.52 (0.47, 0.57) 0.1 1,918 0.50 (0.46, 0.55)
AGP, g/ L 355 0.56 (0.54, 0.59) 1,563 0.56 (0.55, 0.58) 0.8 1,918 0.56 (0.55, 0.58)
Inflammation i , % 36 9.0 (5.5, 12.6) 125 8.5 (6.7, 10.4) 0.8 161 8.6 (7.1, 10.2)
Malaria, % 0 0 0
Helicobacter pylori, % 153 44.2 (36.3, 52.0) 639 38.8 (35.3, 42.4) 0.2 792 39.9 (36.2, 43.6)
Visceral leishmaniasis, % 2 0.6 (0.0, 1.5) 5 0.4 (0.0, 0.8) d 0.6 7 0.4 (0.1, 0.8) d
Soil‐transmitted helminth infection j , % 49 14.2 (9.3, 19.1) 285 19.3 (16.1, 22.6) 0.05 334 18.3 (15.2, 21.4)
G6PD, % 89 25.5 (18.6, 32.3) 145 10.6 (8.4, 12.7) <0.0001 234 13.6 (11.2, 15.9)
Hemoglobinopathies k % 47 17.0 (9.0, 25.0) 44 3.7 (2.2, 5.2) <0.0001 91 6.4 (4.0, 8.8)
Received deworming l , % 161 38.5 (32.0, 44.9) 740 40.4 (36.6, 44.3) 0.6 901 40.0 (36.5, 43.6)
Hormonal birth control use, % 35 8.4 (5.5, 11.3) 322 19.3 (16.8, 21.7) <0.0001 357 17.1 (14.8, 19.3)
Micronutrient status
Serum ferritin m , μg/ L 355 20.4 (17.7, 23.5) 1,563 33.2 (31.6, 35.0) <0.0001 1,918 30.1 (28.6, 31.7)
Iron deficiency n , % 135 38.8 (32.1, 45.6) 198 13.4 (11.1, 15.6) <0.0001 333 18.5 (16.0, 21.0)
Serum sTfR m , mg/ L 355 7.5 (7.1, 8.2) 1,563 5.3 (5.2, 5.5) <0.0001 1,918 5.7 (5.6, 5.9)
Serum RBP, μmol/ L 355 1.21 (1.16, 1.25) 1,563 1.43 (1.41, 1.45) <0.0001 1,918 1.38 (1.36, 1.41)
Vitamin A deficiency o , % 5 1.0 (0.0, 2.0) d 6 0.4 (0.0, 0.9) d 0.2 11 0.5 (0.2, 0.9)
RBC folate, nmol/ L 355 547.5 (513.4, 583.8) 1563 532.9 (509.6, 557.4) 0.4 1,918 535.8 (513.2, 559.4)
Risk of folate deficiency p , % 49 11.9 (8.0, 15.9) 183 10.4 (8.0, 12.8) 0.5 232 10.7 (8.6, 12.8)
Serum zinc, μg/ dL 355 74.4 (70.4, 78.7) 1,563 78.4 (75.5, 81.5) 0.1 1,918 77.6 (75.0, 80.3)
Zinc deficiency q , % 105 28.2 (22.5, 34.0) 380 23.0 (19.8, 26.3) 0.09 485 24.1 (21.1, 27.1)
Dietary and supplement intake
Prior day food consumption, %
Flesh, organ, or blood‐based foods 264 74.6 (68.0, 81.1) 1,065 68.4 (64.6, 72.3) 0.1 1,329 69.7 (66.3, 73.0)
Legumes 89 24.9 (19.3, 30.5) 412 25.1 (21.6, 28.6) 0.9 501 25.1 (21.8, 28.4)
Green, leafy vegetables 191 51.2 (44.8, 57.6) 798 50.0 (45.9, 54.2) 0.7 989 50.3 (46.6, 53.9)
Vitamin A‐rich fruits or vegetables 285 81.0 (76.2, 85.8) 1,257 78.2 (74.3, 82.1) 0.3 1,542 78.8 (75.4, 82.1)
Tea or Tibetan tea 186 55.6 (49.1, 62.1) 965 62.2 (57.5, 66.9) 0.02 1,151 60.9 (56.3, 65.4)
Minimum dietary diversity r 157 46.9 (40.0, 53.8) 738 50.0 (45.5, 54.4) 0.3 895 49.4 (45.0, 53.7)
Pica, % 28 5.6 (2.8, 8.5) 111 5.1 (3.7, 6.5) 0.7 139 5.2 (3.9, 6.5)
Any micronutrient supplement intake s , % 25 5.9 (3.2, 8.7) 85 6.6 (4.6, 8.6) 0.7 110 6.5 (4.8, 8.1)

Note. Ns are unweighted. Values presented are geometric mean (95% CI) or percent (95% CI). All estimates account for weighting and complex sampling design.

Abbreviations: AGP, ɑ‐1 acid glycoprotein; CI, confidence interval; CRP, C‐reactive protein; G6PD, glucose‐6‐phosphate dehydrogenase deficiency; RBC, red blood cell; RBP, retinol binding protein; sTfR, transferrin receptor.

a

Anaemia defined as altitude‐and smoking‐adjusted Hb <12.0 g/ dL (WHO, 2017a).

b

P values calculated for Rao–Scott chi square tests for categorical variables and linear contrast tests for continuous variables.

c

Other Terai cases include Terai/ Madhesi ethnicities not including Terai/ Madhesi Brahmin/ Chettri.

d

Interpret with caution. Estimates may be unstable due to small n.

e

Water source based on self‐report. Improved water source defined as piped water, tube well borehole, protected well or spring, stone tap, rainwater, or bottle water (WHO and UNICEF, 2017).

f

Haemoglobin adjusted for altitude and smoking (WHO, 2017a).

g

Anaemia severity categorized as mild (adjusted Hb 11.0– 11.9 g/ dL), moderate anaemia (adjusted Hb 8.0– 10.9 g/ dL), and severe (adjusted Hb < 8.0 g/ dL; WHO, 2017a).

h

Underweight defined as BMI <18.5 kg/ m2. Normal weight defined as BMI 18.5– 24.9 kg/ m2. Overweight/ obesity defined as BMI ≥25.0 kg/ m2 (WHO, 2004).

i

Inflammation defined as elevated CRP (>5 mg/ L) or elevated AGP (>1 g/ L; Namaste et al., 2017).

j

Soil‐transmitted helminths including hookworm, Trichuris trichura, and Ascaris lumbricodes.

k

Haemoglobinopathies include ɑ‐and β‐thalassemia, haemoglobin E, and sickle cell.

l

Receiving deworming during the 6 months preceding the survey.

m

Biomarker was regression‐adjusted to a pooled country reference to adjust for inflammation, using CRP and AGP (ferritin) or AGP only (sTfR; Namaste et al., 2017).

n

Iron deficiency defined as inflammation‐adjusted serum ferritin <15.0 μg/ L (WHO, 2017a).

o

Vitamin A deficiency was defined as RBP <0.64 μmol/ L. The population‐specific RBP cut‐point equivalent to serum retinol <0.70 μmol/ L was calculated by regressing RBP on retinol in a subsample of 100 WRA for whom serum retinol was assessed using HPLC from the same blood draw as RBP (WHO, 1996).

p

Folate cutoff based on the risk of megaloblastic anaemia defined as RBC folate <305.0 nmol/ L (Institute of Medicine 1998).

q

Zinc deficiency defined as serum zinc <66.0 μg/ dL for nonfasted, morning (i. e. before 12 pm) samples and < 59.0 μg/ dL for nonfasted, afternoon (i. e. after 12 p.m.) samples (IZiNCG 2012).

r

Minimum dietary diversity defined as intake from ≥5 of the 10 main food groups (grains, legumes, nuts, dairy, flesh foods, eggs, green leafy vegetables, vitamin A‐rich fruits and vegetables, other fruits, and other vegetables) the day preceding the survey based on Food and Agriculture Organization recommendations for minimum dietary diversity for women (FAO and FHI 360, 2016).

s

Micronutrient supplement intake includes: multivitamin, iron–folic acid tablets, iron tablets, and/or zinc tablets consumed the 7 days preceding the survey.